AstraZeneca and Fresenius Medical Care will exit the kidney disease treatment developer in a $725m acquisition that could potentially rise to $2.1bn.

The social media operator is seeking a head of investments for its NPE subsidiary who will reportedly work with Gradient Ventures alumnus Shabih Rizvi.

Novo co-led the series C round with Longitude Capital and Checkmate will use the cash to advance clinical development of its lead asset, which is targeting melanoma.

The Bloomberg-backed data science management platform increased its overall funding to $128m in a round featuring Dell Technologies Capital.

UCeed will target four to eight healthcare projects with a focus on child medicine, investing up to $220,000 per transaction.

Francisco Partners has injected $30m into Kyruus, five months after the patient-matching platform developer received $42m in a series D round featuring Salesforce and Providence St Joseph.

Dell Technologies Capital and Wipro Ventures contributed to a round that advanced the total raised by the open source database software provider to $55m.

GCV Rising Star David Schulte has taken up a senior vice-president role to oversee McKesson’s strategic investment arm, after previous unit head Tom Rodgers ascended to chief strategy officer.

Boston Consulting Group returned with the rest of Journera's series A investors to provide $11.6m for the travel data exchange service.

The mobile optimisation technology provider, whose backers include Verizon Ventures, is set to be bought by Volaris Group.